Search
Powered By HealthLine
Health Tools
 Pain Management
 Pain Management Drug Info
 Chronic Pain Q&A
 Chronic Pain Forum
 Fibromyalgia Quiz
Featured Conditions
 Chronic Pain
 Osteoarthritis
 Rheumatoid Arthritis
 Osteoporosis
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Drug DescriptionSide Effects & Drug InteractionsWarnings & Precautions
Clinical PharmacologyOverdosage & ContraindicationsIndications & DosagePatient Info

Monopril

[Fosinopril]


Side Effects & Drug Interactions
ADVERSE REACTIONS

MONOPRIL (fosinopril sodium tablets) has been evaluated for safety in more than 2100 individuals in hypertension and heart failure trials, including approximately 530 patients treated for a year or more. Generally adverse events were mild and transient, and their frequency was not prominently related to dose within the recommended daily dosage range.

Hypertension In placebo-controlled clinical trials (688 MONOPRIL-treated patients), the usual duration of therapy was two to three months. Discontinuations due to any clinical or laboratory adverse event were 4.1% and 1.1% in MONOPRIL-treated and placebo-treated patients, respectively. The most frequent reasons (0.4 to 0.9%) were headache, elevated transaminases, fatigue, cough (see PRECAUTIONS: General, Cough), diarrhea, and nausea and vomiting. During clinical trials with any MONOPRIL (fosinopril sodium tablets) regimen, the incidence of adverse events in the elderly ( 65 years old) was similar to that seen in younger patients.

Text Continues Below



Clinical adverse events probably or possibly related or of uncertain relationship to therapy, occurring in at least 1% of patients treated with MONOPRIL alone and at least as frequent on MONOPRIL as on placebo in placebo-controlled clinical trials are shown in the table below.

Clinical Adverse Events in Placebo-Controlled Trials (Hypertension)
MONOPRIL Placebo (N= 688) (N= 184)
Incidence Incidence (Discontinuation) (Discontinuation)

Cough 2.2 (0.4) 0.0 (0.0)
Dizziness 1.6 (0.0) 0.0 (0.0)
Nausea/ Vomiting 1.2 (0.4) 0.5 (0.0)

The following events were also seen at >1% on MONOPRIL but occurred in the placebo group at a greater rate: headache, diarrhea, fatigue, and sexual dysfunction.

Other clinical events probably or possibly related, or of uncertain relationship to ther-apy occurring in 0.2 to 1.0% of patients (except as noted) treated with MONOPRIL in controlled or uncontrolled clinical trials (N = 1479) and less frequent, clinically sig-nificant events include (listed by body system):

Page:  1 | 2 | 3 | 4 | 5 | Next >>







HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire